GENEVA, Aug. 6 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, California 91320-1799) filed a patent application (PCT/US2025/012579) for "METHODS FOR MODULATING MONOCLONAL ANTIBODY CHARGE VARIANTS" on Jan 22, 2025. With publication no. WO/2025/160161, the details related to the patent application was published on Jul 31, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CAIRNS, Grant J. (c/o Amgen Inc., One Amgen Center DriveLaw Department - Patent Operations M/S 28-5-AThousand Oaks, California 91320-1799), TAN, Li Xuan (c/o Amgen Inc., One Amgen Center DriveLaw Department - Patent Operati...